- Home
- QURE vs BTQ Comparison
QURE vs BTQ Comparison
Compare QURE & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- BTQ
- Stock Information
- Founded
- QURE 1998
- BTQ 1983
- Country
- QURE Netherlands
- BTQ Canada
- Employees
- QURE N/A
- BTQ N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- BTQ
- Sector
- QURE Health Care
- BTQ
- Exchange
- QURE Nasdaq
- BTQ Nasdaq
- Market Cap
- QURE 866.3M
- BTQ 728.0M
- IPO Year
- QURE 2007
- BTQ N/A
- Fundamental
- Price
- QURE $64.16
- BTQ $12.55
- Analyst Decision
- QURE Strong Buy
- BTQ
- Analyst Count
- QURE 12
- BTQ 0
- Target Price
- QURE $69.67
- BTQ N/A
- AVG Volume (30 Days)
- QURE 7.5M
- BTQ 6.3M
- Earning Date
- QURE 11-04-2025
- BTQ 11-14-2025
- Dividend Yield
- QURE N/A
- BTQ N/A
- EPS Growth
- QURE N/A
- BTQ N/A
- EPS
- QURE N/A
- BTQ N/A
- Revenue
- QURE $14,337,000.00
- BTQ $653,726.00
- Revenue This Year
- QURE N/A
- BTQ $100.70
- Revenue Next Year
- QURE $287.72
- BTQ $669.96
- P/E Ratio
- QURE N/A
- BTQ N/A
- Revenue Growth
- QURE N/A
- BTQ 884.39
- 52 Week Low
- QURE $5.23
- BTQ $0.18
- 52 Week High
- QURE $65.12
- BTQ $16.00
- Technical
- Relative Strength Index (RSI)
- QURE 83.29
- BTQ N/A
- Support Level
- QURE $50.80
- BTQ N/A
- Resistance Level
- QURE $57.57
- BTQ N/A
- Average True Range (ATR)
- QURE 5.17
- BTQ 0.00
- MACD
- QURE 1.67
- BTQ 0.00
- Stochastic Oscillator
- QURE 97.47
- BTQ 0.00
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.